**Target Corp. Names New CEO: What This Means for Investors**
**A New Era of Leadership at Target Corp.**
In a move that’s likely to send ripples th…
Target Names Insider as CEO to Lead Turnaround
Currently browsing: Global Market
Demand for Physical Gold Is Still High, Says Abaxx CEO
**Gold Rush: How Trump’s Tariffs Boosted Demand for the Precious Metal**
**market Context: Tariffs and Volatility**
The ongoing trade tensions betwe…
FDA approves first-ever glucose monitoring system for weight loss from Signos
**Revolutionizing Diabetes Management: Signos’ AI-Powered CGM System Gains Traction**
**A New Era in Diabetes Care**
In a significant development, S…
Stock Rally Pauses After Wall Street Tech Selloff: Markets Wrap
**Global Stocks Selloff: What’s Behind the Sharp Reversal?**
**market Momentum Lost as Tech Giants Take a Hit**
The unprecedented rally in global st…
Nvidia-Led Tech Selloff Hits Asian Stocks | Bloomberg: The Asia Trade, 8/20/25
Here is a rewritten version of the original text as a well-structured, SEO-optimized blog article:
**Staying Ahead in Asia’s markets: Insights and An…
Oil Steady as Industry Report Points to Shrinking US Stockpiles
**Oil Prices Stabilize Amidst Geopolitical Tensions and Inventory Decline**
The global oil market has been experiencing a tumultuous ride in recent w…
The senior living market can’t keep up with demand as boomers age
**The Silver Tsunami: How Aging Boomers Are Reshaping the Senior Living Industry**
**A Demographic Shift with Investment Implications**
The United S…
From sweet treats to protein boosts, chains are banking on beverages to drive sales
**Beverage Bonanza: How Chains Like McDonald’s and Starbucks are Driving Sales with New Drinks**
The beverage market is buzzing with activity as chai…
MTA Plans to Raise Fare to $3 in 2026
**Unlocking the Financial Reality of NYC’s Subway System: A $2 Billion Investment and Beyond**
**The Subway System’s Financial Landscape**
The Metro…
Viking Therapeutics shares fall 40% on disappointing obesity pill trial data
**Weight Loss and Diabetes Drug market: Eli Lilly and Novo Nordisk Poised to Strengthen Dominance**
The pharmaceutical industry is abuzz with anticip…